We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
19 Aug 2022 - PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results for the first half of […]
Read morePolyPeptide provides market update
12 Jul 2022 - The EBITDA margin for the first half of 2022 is expected to be around 20% of revenue. Media Release – ad hoc announcement pursuant to Art. […]
Read morePolyPeptide wins Malmö Life Science Business Award
28 Jun 2022 - Malmö, 21 June 2022 We are proud of our site in Malmö, Sweden, for winning the Life Science Business Award of the city (Malmö Näringslivspris Life […]
Read moreMonika Casanova joining PolyPeptide as CHRO and member of the PMC
9 May 2022 - With 19 years of HR experience, the native German most recently worked as head of global HR for a building materials company.
Read morePolyPeptide announces results of the annual General Meeting 2022
26 Apr 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide development and manufacturing, today announced that the shareholders approved all proposals put forward by the Board of […]
Read morePolyPeptide publishes invitation to the annual General Meeting 2022
1 Apr 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published today the invitation to its first annual General Meeting which will take […]
Read morePolyPeptide achieves strong profitable growth in 2021
15 Mar 2022 - PolyPeptide Group AG (SIX: PPGN), a global leader in peptide custom development and manufacturing, today announced its results for the financial year 2021: Revenue growth of […]
Read moreGreen Chemistry Articles of Interest to the Pharmaceutical Industry
13 Mar 2022 - Bryan, M. C.; Dalton, C.; Díaz-Rodríguez, A.; Doerfler, J.; Engl, O. D.; Ferguson, P.; Molina, A. G.; Han, Z. S.; Hosford, J.; Howell, G. P.; Hutchby, M.; Li, W.; Munday, R. H.; Navarro, A.; Parmentier, M.; Pawlas, J.; Richardson, P. F.; Smith III, W. J.; Steven, A.; Takale, B. S.; Terrett, J. A.; Treitler, D. S.; Zeng, M. Org. Process Res. Dev. 2022, 26, 2, 251–262Publication Date: February 2, 2022 […]
Read moreEnvironmentally Sensible Organocatalytic Fmoc/t Bu Solid-Phase Peptide Synthesis
28 Feb 2022 - We now report a proof-of-principle Fmoc/t-Bu SPPS in which both couplings and Fmoc deprotections were catalyzed by readily available reagents in an inexpensive green solvent. […]
Read more